pharmaceutical jobs, careers, and e-learning/training Employers, Biotechnology And Pharmaceutical Firms: Subscribe Now, Post Your Job Openings, Search Resumes, Find Candidates Pharmaceutical Job Search Post Your Pharm/biotech Resume               
  Pharmaceutical Jobs, Learning Resources, Career Tools

  Home | Discussions | Education | Job Search | Focus Areas | Career Tools | Support | Login | Employers & Recruiters

Forums 24x7

Calendar

News Articles

Focus Areas

Links & Resources

Bookstore

Free Magazines



  Print This Page


Pfizer Takes 12% of Perlegen Sciences


Press Release
December 28, 2005

LOS ANGELES, CA, (NAMC) – On Tuesday, Perlegen Sciences, Inc. made the announcement that Pfizer Inc (NYSE: PFE) has invested over $50 million in Perlegen, taking approximately twelve (12) percent of the co mpany.

Pfizer and Perlegen entered into their first research collaboration in December 2002, using Perlegen's DNA sample preparation, high resolution SNP genotyping, and data analysis capabilities to discover genes associated with common diseases and identify genetic markers that may predict patient response to medicines.

Perlegen Sciences co-founder and CEO, Brad Margus, said "We all recognize the challenges and risks that drug discovery and development poise. Industry-wide, many new drugs have been discontinued in late-stage trials, after hundreds of millions of dollars have been invested. Many times this results because a subset of patients responded differently from the rest."

Michael Rossi
Business News Correspondent
NAMC Newswire
www.namcnewswire.com


Print This Page

About hireRx  ::  Copyright  ::  Privacy  ::  Legal  ::  Contact